{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:17:43Z","timestamp":1793038663579,"version":"4.5.0"},"reference-count":26,"publisher":"SAGE Publications","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAD"],"published-print":{"date-parts":[[2023,12,6]]},"abstract":"<jats:p>Background: Recent studies have identified a relationship between elevated homocysteine levels and hypertension (HTN) with Alzheimer\u2019s disease (AD), but its pathogenesis remains unclear. Objective: To evaluate elevated homocysteine levels and HTN as risk factors for cognitive impairment (CI) and determine their relationship with white matter hyperintensity (WMH) volume. Methods: A total of 521 subjects were selected from the Alzheimer\u2019s Disease Neuroimaging Initiative (ADNI) database and divided into two groups according to the diagnostic criteria of the ADNI database. The CI group included 370 subjects, consisting of 122 with AD and 248 with mild CI, while the cognitively normal (CN) group contained 151 subjects. The history of HTN, homocysteine levels, WMH volume and Mini-Mental State Examination (MMSE) scores were analyzed. Results: The study found that patients with CI had higher homocysteine levels than those with CN. Additionally, WMH volume was significantly correlated with homocysteine levels in CI patients, and MMSE scores decreased as WMH volume increased. Further analysis revealed that CI patients with HTN had significantly higher homocysteine levels than those without HTN. Furthermore, the correlation between WMH volume and homocysteine levels was significant only in CI patients with HTN and not in those without HTN. In CN patients, there was no correlation between WMH volume and homocysteine levels in either the HTN or non-HTN groups, and no difference was observed in homocysteine levels. Conclusions: It is indicated that elevated homocysteine levels in conjunction with HTN are associated with the increased volume of WMHs and CI.<\/jats:p>","DOI":"10.3233\/jad-230687","type":"journal-article","created":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T11:33:58Z","timestamp":1700566438000},"page":"1739-1746","source":"Crossref","is-referenced-by-count":10,"title":["Elevated Homocysteine Levels and Hypertension Relate to Cognitive Impairment via Increased White Matter Hyperintensity Volume"],"prefix":"10.1177","volume":"96","author":[{"given":"Yuan","family":"Gao","sequence":"first","affiliation":[{"name":"Department of Neurology, The First Hospital of Hebei Medical University, Brain Aging and Cognitive Neuroscience Laboratory of Hebei Province, Shijiazhuang, Hebei, China"},{"name":"Department of Cell Biology, Hebei Medical University, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Alzheimer\u2019s Disease Neuroimaging Initiative","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaocui","family":"Duan","sequence":"additional","affiliation":[{"name":"Department of Cell Biology, Hebei Medical University, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlin","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Hebei Medical University, Brain Aging and Cognitive Neuroscience Laboratory of Hebei Province, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The First Hospital of Hebei Medical University, Brain Aging and Cognitive Neuroscience Laboratory of Hebei Province, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Xian","sequence":"additional","affiliation":[{"name":"Department of Pathophysiology, Hebei Medical University, Shijiazhuang, Hebei, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhu","sequence":"additional","affiliation":[{"name":"Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine Geriatrics Department, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hualong","family":"Wang","sequence":"additional","affiliation":[{"name":"Ruijin Hospital Affiliated to Shanghai Jiaotong University School of Medicine Geriatrics Department, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","reference":[{"key":"10.3233\/JAD-230687_ref1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.cell.2019.09.001","article-title":"Alzheimer disease: An update on pathobiology and treatment strategies","volume":"179","author":"Long","year":"2019","journal-title":"Cell"},{"key":"10.3233\/JAD-230687_ref2","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jalz.2011.03.005","article-title":"The diagnosis of dementia due to Alzheimer\u2019s disease: Recommendations from the National Institute on Aging-Alzheimer\u2019s Association workgroups on diagnostic guidelines for Alzheimer\u2019s disease","volume":"7","author":"McKhann","year":"2011","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230687_ref3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.exger.2017.10.008","article-title":"Homocysteine concentrations in the cognitive progression ofAlzheimer\u2019s disease","volume":"99","author":"Farina","year":"2017","journal-title":"Exp Gerontol"},{"key":"10.3233\/JAD-230687_ref4","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIRCRESAHA.118.313400","article-title":"Cerebrovascular alterations in Alzheimer disease","volume":"123","author":"Iadecola","year":"2018","journal-title":"Circ Res"},{"key":"10.3233\/JAD-230687_ref5","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1017\/S1041610211000779","article-title":"Plasma homocysteine and cognitive decline in older hypertensive subjects","volume":"23","author":"Narayan","year":"2011","journal-title":"Int Psychogeriatr"},{"key":"10.3233\/JAD-230687_ref6","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.3389\/fneur.2019.01174","article-title":"Differential impact of plasma homocysteine levels on the periventricular and subcortical white matter hyperintensities on the brain","volume":"10","author":"Lee","year":"2019","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-230687_ref7","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.nicl.2015.04.017","article-title":"The effects of white matter hyperintensities and amyloid deposition on Alzheimer dementia","volume":"8","author":"Gordon","year":"2015","journal-title":"Neuroimage Clin"},{"key":"10.3233\/JAD-230687_ref8","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1159\/000109755","article-title":"PENN biomarker core of the Alzheimer\u2019s disease Neuroimaging Initiative","volume":"16","author":"Shaw","year":"2008","journal-title":"Neurosignals"},{"key":"10.3233\/JAD-230687_ref9","first-page":"239","article-title":"Fully-automated white matter hyperintensity detection with anatomical prior knowledge and without FLAIR","volume":"21","author":"Schwarz","year":"2009","journal-title":"Inf Process Med Imaging"},{"key":"10.3233\/JAD-230687_ref10","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1056\/NEJMoa011613","article-title":"Plasma homocysteine as a risk factor for dementia and Alzheimer\u2019s disease","volume":"346","author":"Seshadri","year":"2002","journal-title":"N Engl J Med"},{"key":"10.3233\/JAD-230687_ref11","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3390\/biomedicines10112741","article-title":"Homocysteine, cognitive functions, and degenerative dementias: State of the art","volume":"10","author":"Luzzi","year":"2022","journal-title":"Biomedicines"},{"key":"10.3233\/JAD-230687_ref12","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","article-title":"White matter hyperintensities, cognitive impairment and dementia: An update","volume":"11","author":"Prins","year":"2015","journal-title":"Nat Rev Neurol"},{"key":"10.3233\/JAD-230687_ref13","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1093\/ajcn\/77.3.668","article-title":"Homocysteine and cognitive function in healthy elderly community dwellers in Italy","volume":"77","author":"Ravaglia","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.3233\/JAD-230687_ref14","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/gps.2303","article-title":"Homocysteine as a predictor of cognitive decline in Alzheimer\u2019s disease","volume":"25","author":"Oulhaj","year":"2010","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.3233\/JAD-230687_ref15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1001\/archneur.59.5.787","article-title":"Plasma homocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease","volume":"59","author":"Hogervorst","year":"2002","journal-title":"Arch Neurol"},{"key":"10.3233\/JAD-230687_ref16","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s10072-007-0832-y","article-title":"Plasma homocysteine and severe white matter disease","volume":"28","author":"Censori","year":"2007","journal-title":"Neurol Sci"},{"key":"10.3233\/JAD-230687_ref17","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1161\/STROKEAHA.114.007146","article-title":"Relationship between white matter hyperintensities, cortical thickness, and cognition","volume":"46","author":"Tuladhar","year":"2015","journal-title":"Stroke"},{"key":"10.3233\/JAD-230687_ref18","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1161\/CIRCULATIONAHA.110.978114","article-title":"Hypertension, white matter hyperintensities, and concurrent impairments in mobility, cognition, and mood: The Cardiovascular Health Study","volume":"123","author":"Hajjar","year":"2011","journal-title":"Circulation"},{"key":"10.3233\/JAD-230687_ref19","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/alz.12866","article-title":"Associations among hypertension, dementia biomarkers, andcognition: The MEMENTO cohort","volume":"19","author":"Lespinasse","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.3233\/JAD-230687_ref20","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1161\/01.STR.0000125859.71051.83","article-title":"Interaction between hypertension, apoE, and cerebral white matter lesions","volume":"35","author":"De Leeuw","year":"2004","journal-title":"Stroke"},{"key":"10.3233\/JAD-230687_ref21","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1177\/0091270003258190","article-title":"Homocysteine and essential hypertension","volume":"43","author":"Rodrigo","year":"2003","journal-title":"J Clin Pharmacol"},{"key":"10.3233\/JAD-230687_ref22","doi-asserted-by":"crossref","first-page":"740819","DOI":"10.3389\/fneur.2021.740819","article-title":"Hypertension with high homocysteine is associated with default network gray matter loss","volume":"12","author":"Kong","year":"2021","journal-title":"Front Neurol"},{"key":"10.3233\/JAD-230687_ref23","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.patbio.2012.04.003","article-title":"[Homocysteine, vitamin B-12, folic acid and the cognitive decline in the elderly]","volume":"61","author":"Smach","year":"2013","journal-title":"Pathol Biol (Paris)"},{"key":"10.3233\/JAD-230687_ref24","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1001\/jama.300.15.1774","article-title":"High-dose B vitamin supplementation and cognitive decline in Alzheimer disease: A randomized controlled trial","volume":"300","author":"Aisen","year":"2008","journal-title":"JAMA"},{"key":"10.3233\/JAD-230687_ref25","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1007\/s11239-012-0856-x","article-title":"Lowering homocysteine levels with folic acid and B-vitamins do not reduce early atherosclerosis, but could interfere with cognitive decline and Alzheimer\u2019s disease","volume":"36","author":"Cacciapuoti","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"10.3233\/JAD-230687_ref26","doi-asserted-by":"crossref","first-page":"9523","DOI":"10.1073\/pnas.1301816110","article-title":"Preventing Alzheimer\u2019s disease-related gray matter atrophy by B-vitamin treatment","volume":"110","author":"Douaud","year":"2013","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Journal of Alzheimer's Disease"],"original-title":[],"link":[{"URL":"https:\/\/content.iospress.com\/download?id=10.3233\/JAD-230687","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T10:08:56Z","timestamp":1777370936000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/full\/10.3233\/JAD-230687"}},"subtitle":[],"editor":[{"given":"Lingqiang","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2023,12,6]]},"references-count":26,"journal-issue":{"issue":"4"},"URL":"https:\/\/doi.org\/10.3233\/jad-230687","relation":{},"ISSN":["1387-2877","1875-8908"],"issn-type":[{"value":"1387-2877","type":"print"},{"value":"1875-8908","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,6]]}}}